• Thumbnail for Convidecia
    Convidecia (redirect from Ad5-nCoV)
    AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino...
    36 KB (3,379 words) - 00:52, 31 December 2023
  • Thumbnail for Adenoviridae
    Adenoviridae (redirect from Ad5)
    Recombinant adenovirus type-5 (Ad5) are being used by Ad5-nCoV, ImmunityBio and UQ-CSL V451. The Gam-COVID-Vac (aka Sputnik-V) product is innovative because...
    49 KB (5,557 words) - 01:25, 8 March 2024
  • Thumbnail for CanSino Biologics
    company has a portfolio of vaccines under research including Ad5-EBOV to prevent Ebola and Ad5-nCoV for COVID-19. The company has previously collaborated with...
    15 KB (1,091 words) - 19:31, 11 November 2023
  • V by the Gamaleya Institute (February 2, 2021) Ad5-nCoV by CanSino Biologics Inc. (February 9, 2021) CoronaVac by Sinovac Research and Development Co...
    10 KB (796 words) - 15:33, 1 January 2024
  • AD-5 (redirect from AD5)
    5AD (radio station), Adelaide, South Australia, Australia Ad5-nCoV, COVID-19 vaccine Ad5-EBOV, Ebola vaccine 5 (disambiguation) AD (disambiguation) This...
    789 bytes (149 words) - 17:39, 2 October 2021
  • tozinameran and mRNA-1273, the DNA vaccine ZyCoV-D as well as the viral vectors AZD1222, Ad26.COV2.S, Ad5-nCoV, and Sputnik V. In addition, genetic vaccines are...
    8 KB (1,186 words) - 19:47, 27 October 2022
  • Thumbnail for Academy of Military Medical Sciences
    clinical trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax". Reuters. 2020-12-07. Retrieved 2020-12-07. Eltahir N (9 August 2020). "CanSino to start Phase...
    12 KB (1,000 words) - 22:12, 7 March 2024
  • Thumbnail for Chen Wei (medical scientist)
    trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax". Reuters. 7 December 2020. Retrieved 7 December 2020. Eltahir N (9 August 2020). "CanSino to start...
    15 KB (1,075 words) - 05:06, 9 April 2024
  • Thumbnail for COVID-19 vaccination in Canada
    Biologics to conduct clinical trials for its COVID-19 vaccine candidate Ad5-nCoV at Dalhousie University in Nova Scotia. The NRC cited its "strong collaborative...
    166 KB (13,886 words) - 11:39, 30 April 2024
  • Biological Sciences at the University of Montreal. Starting in June, the Ad5-nCoV vaccine, developed by the Chinese company CanSino Biologics (Tianjin, China)...
    180 KB (17,227 words) - 15:36, 6 March 2024